
1. General Information
RaloxiHeal 60 mg Tablets contain Raloxifene Hydrochloride 60 mg, a selective estrogen receptor modulator (SERM). It is primarily prescribed for the treatment and prevention of osteoporosis in postmenopausal women. Raloxifene can help reduce bone loss and improve bone strength, thereby lowering the risk of certain fractures. It is also approved in appropriate postmenopausal women for reducing the risk of invasive breast cancer.
Phoenix Exim is a pharmaceutical exporter from Nagpur, India, supplying a range of pharmaceutical products for international markets including the USA, UK, Australia, Singapore, Canada, South Korea and UAE, subject to applicable import and regulatory requirements.
2. Product Information
- Brand: RaloxiHeal
- Active Ingredient: Raloxifene Hydrochloride
- Strength: 60 mg
- Dosage Form: Tablet
- Therapeutic Class: Selective Estrogen Receptor Modulator (SERM)
- Route: Oral
- Primary Use: Prevention and treatment of osteoporosis in postmenopausal women
- Typical labeled dose: 60 mg once daily, as prescribed by a healthcare professional.
3. Uses of RaloxiHeal 60 mg
RaloxiHeal 60 mg may be prescribed for:
- Treatment of osteoporosis in postmenopausal women
- Prevention of osteoporosis after menopause
- Reducing the risk of invasive breast cancer in certain postmenopausal women
- Helping maintain bone mineral density
- Reducing the risk of vertebral fractures associated with osteoporosis
Raloxifene is not indicated for treating invasive breast cancer itself or for preventing recurrence of breast cancer.
4. Benefits of This Medicine
When appropriately prescribed, RaloxiHeal 60 mg may:
- Help slow postmenopausal bone loss
- Improve or maintain bone mineral density
- Reduce the risk of vertebral fractures
- Support long-term bone health
- Reduce the risk of invasive breast cancer in certain eligible postmenopausal women
The medicine works differently from conventional estrogen replacement and has estrogen-like effects on some tissues while blocking estrogen effects on others.
5. Side Effects of RaloxiHeal 60 mg
Like other prescription medicines, raloxifene may cause side effects. Important or potentially serious adverse effects include:
- Blood clots in the veins
- Deep vein thrombosis (DVT)
- Pulmonary embolism (PE)
- Retinal vein thrombosis
- Increased risk of fatal stroke in certain high-risk women
The risk of venous thromboembolism is an important safety concern with raloxifene.
6. Common Side Effects
Reported side effects can include:
- Hot flashes
- Leg cramps
- Swelling of the extremities
- Flu-like symptoms
- Joint or muscle discomfort
- Sweating
Patients should contact a healthcare professional if symptoms are persistent, severe, or unusual.
Seek urgent medical attention for symptoms that may indicate a blood clot, such as sudden chest pain, difficulty breathing, coughing blood, or unexplained pain/swelling in one leg.
7. How to Use RaloxiHeal 60 mg
- Take the tablet orally once daily, or exactly as directed by your doctor.
- It can generally be taken with or without food.
- Swallow the tablet with water.
- Take it at approximately the same time each day to maintain consistency.
- Do not change the dose or stop treatment without medical advice.
- If you miss a dose, follow your healthcare professional's instructions rather than taking extra tablets.
The labeled dosage for raloxifene hydrochloride tablets is 60 mg once daily.
8. How RaloxiHeal 60 mg Works
Raloxifene is a selective estrogen receptor modulator (SERM). It binds to estrogen receptors and produces estrogen-like effects in some tissues while acting as an estrogen antagonist in others.
In bone tissue, its estrogen-like activity helps reduce bone resorption and bone loss associated with menopause. This can help maintain bone mineral density and reduce the risk of vertebral fractures.
9. Safety Advice for This Medicine
- Use only under the supervision of a qualified healthcare professional.
- Do not use raloxifene if you have an active or previous history of venous thromboembolism, including DVT, pulmonary embolism, or retinal vein thrombosis.
- Raloxifene is contraindicated during pregnancy because it may cause fetal harm.
- It is not recommended for premenopausal women.
- Tell your doctor if you have cardiovascular disease or risk factors for stroke.
- Raloxifene should not be used for primary or secondary prevention of cardiovascular disease.
- Tell your doctor about all medicines and supplements you take.
- Raloxifene is not recommended together with systemic estrogen therapy.
- During prolonged immobilization, such as major surgery or extended bed rest, medical advice is required because of clotting risk; prescribing information advises discontinuation before and during prolonged immobilization.
- Calcium and vitamin D intake should be adequate when raloxifene is being used for osteoporosis, according to individual medical advice.
10. Frequently Asked Questions
Q1. What is RaloxiHeal 60 mg used for?
RaloxiHeal 60 mg is primarily used for the treatment and prevention of osteoporosis in postmenopausal women. It can also reduce the risk of invasive breast cancer in certain eligible postmenopausal women.
Q2. What is the active ingredient in RaloxiHeal 60 mg?
The active ingredient is Raloxifene Hydrochloride 60 mg.
Q3. How often is raloxifene taken?
The standard labeled dosage is 60 mg once daily, unless the prescribing physician gives different instructions.
Q4. Is RaloxiHeal an estrogen medicine?
Raloxifene is not conventional estrogen replacement therapy. It is a selective estrogen receptor modulator (SERM) with estrogen-like and estrogen-blocking effects in different tissues.
Q5. Can men take RaloxiHeal 60 mg?
Raloxifene's approved indications are primarily for postmenopausal women. Men should not use it unless specifically directed by a qualified healthcare professional.
Q6. Can RaloxiHeal prevent all types of breast cancer?
No. Raloxifene is indicated for reducing the risk of invasive breast cancer in certain postmenopausal women. It is not indicated for treating invasive breast cancer or reducing recurrence.
Q7. Is RaloxiHeal suitable during pregnancy?
No. Raloxifene is contraindicated during pregnancy because it may cause fetal harm.
Q8. What is the major safety concern with raloxifene?
A major concern is an increased risk of venous thromboembolism, including DVT and pulmonary embolism.
11. Substitute for RaloxiHeal 60 mg
Potential alternatives depend on the reason for treatment, bone density, fracture risk, age, medical history and other medicines. A healthcare professional may consider other osteoporosis medicines such as:
- Alendronate
- Risedronate
- Ibandronate
- Zoledronic acid
- Denosumab
- Teriparatide or other anabolic osteoporosis therapies
These medicines are not direct substitutes in every patient and have different indications, dosing schedules and safety considerations. A doctor should determine the appropriate alternative.
12. SEO Keywords
Primary keywords:
- RaloxiHeal 60 mg Tablets
- RaloxiHeal 60 mg
- Raloxifene 60 mg Tablets
- Raloxifene Hydrochloride 60 mg
- Raloxifene tablets exporter
- Raloxifene 60 mg supplier
- Raloxifene 60 mg pharmaceutical exporter
- RaloxiHeal 60 mg exporter from India
- RaloxiHeal 60 mg supplier India
- Raloxifene medicine exporter India
Long-tail B2B keywords:
- RaloxiHeal 60 mg Tablets pharmaceutical exporter from India
- Raloxifene Hydrochloride 60 mg tablets supplier from India
- RaloxiHeal 60 mg wholesale pharmaceutical supplier India
- Raloxifene 60 mg tablets exporter from Nagpur India
- RaloxiHeal 60 mg medicine exporter for international markets
- Raloxifene 60 mg tablets wholesale supplier India
- RaloxiHeal 60 mg tablets international pharmaceutical exporter
- Raloxifene Hydrochloride 60 mg bulk medicine supplier
- RaloxiHeal 60 mg tablets exporter to USA UK Australia Canada
- Raloxifene 60 mg pharmaceutical supplier to Singapore UAE South Korea
- RaloxiHeal 60 mg tablets export supplier from Nagpur
- Raloxifene Hydrochloride medicine wholesale exporter India
- RaloxiHeal osteoporosis medicine supplier India
- Raloxifene 60 mg osteoporosis tablets exporter
- RaloxiHeal 60 mg tablets B2B pharmaceutical supplier
Keywords







